Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MHC transmission: insights into gender bias in MS susceptibility.
US patent office grants patent claiming dosing regimen for TECFIDERA™ (dimethyl fumarate)
Spotlight on teriflunomide.
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Gender and the hygiene hypothesis.
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Testosterone treatment in multiple sclerosis: a pilot study.
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis.
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
GlaxoSmithKline Protocol Summaries: Firategrast
The natural history of primary progressive MS in British Columbia, Canada.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
The relevance of animal models in multiple sclerosis research.
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.

Pages